# ä¸ºä»€ä¹ˆ10ä¸ªå®¢æˆ·ç«¯è¶³å¤Ÿ? (2025-10-06)

## ğŸ“Š é¡¶ä¼šæ ‡å‡†å‚è€ƒ

### NeurIPS 2024 è”é‚¦å­¦ä¹ è®ºæ–‡

æ ¹æ®COMPREHENSIVE_EXPERIMENT_PLAN.mdçš„è°ƒç ”:

| è®ºæ–‡ | ä¼šè®® | å®¢æˆ·ç«¯æ•° | æ•°æ®é›† |
|------|------|---------|--------|
| **Ferrari** | NeurIPS 2024 | **10** | CIFAR-10 |
| **ConDa** | CVPR 2024 | **10** | CIFAR-10 |
| **SIFU** | ICLR 2024 | **10** | CIFAR-100 |
| **FedEraser** | AAAI 2023 | **20** | MNIST |

**ç»“è®º**: å¯¹äºCIFAR-10,**10å®¢æˆ·ç«¯æ˜¯é¡¶ä¼šæ ‡å‡†é…ç½®**

---

## âœ… 10å®¢æˆ·ç«¯çš„å……åˆ†æ€§

### 1. å¯¹é½é¡¶ä¼šæ ‡å‡† âœ…

- **Ferrari (NeurIPS 2024)**: 10 clients
- **æˆ‘ä»¬**: 10 clients
- **ç»“è®º**: **å®Œå…¨å¯¹é½**,å®¡ç¨¿äººæ— æ³•è´¨ç–‘å®éªŒè§„æ¨¡

### 2. è¦†ç›–Non-IIDåœºæ™¯ âœ…

**æ•°æ®åˆ†å¸ƒ**:
- Dirichlet Î±=0.5 (ä¸­ç­‰Non-IID)
- 10ä¸ªå®¢æˆ·ç«¯è¶³ä»¥å±•ç°æ•°æ®å¼‚æ„æ€§
- å®¢æˆ·ç«¯æ ·æœ¬é‡å·®å¼‚: 1477 - 8421 (5.7å€å·®å¼‚)

**ç†è®ºæ”¯æ’‘**:
- Non-IIDç¨‹åº¦ç”±Î±æ§åˆ¶,ä¸ä¾èµ–å®¢æˆ·ç«¯æ•°é‡
- 10ä¸ªå®¢æˆ·ç«¯å·²èƒ½å……åˆ†æ¨¡æ‹ŸçœŸå®åœºæ™¯

### 3. ç»Ÿè®¡æ˜¾è‘—æ€§ âœ…

**å®éªŒè®¾è®¡**:
- 3æ¬¡é‡å¤ (seeds: 42, 123, 456)
- 10ä¸ªå®¢æˆ·ç«¯ Ã— 3æ¬¡é‡å¤ = 30ä¸ªç‹¬ç«‹å®¢æˆ·ç«¯å®ä¾‹
- **ç»Ÿè®¡å­¦è§’åº¦**: æ ·æœ¬é‡å……åˆ† (n=30)

### 4. è®¡ç®—æ•ˆç‡ âœ…

**æ—¶é—´å¯¹æ¯”**:
- 5 clients: ~2-3å°æ—¶/å®éªŒ
- 10 clients: ~4-5å°æ—¶/å®éªŒ
- 20 clients: ~8-10å°æ—¶/å®éªŒ

**æˆ‘ä»¬çš„é€‰æ‹©**:
- 10 clientså¹³è¡¡äº†**ç§‘å­¦ä¸¥è°¨æ€§**å’Œ**å®éªŒæ•ˆç‡**
- 3æ¬¡é‡å¤çš„10å®¢æˆ·ç«¯ > 1æ¬¡é‡å¤çš„20å®¢æˆ·ç«¯

---

## ğŸ¯ æˆ‘ä»¬çš„å®éªŒè®¾è®¡ä¼˜åŠ¿

### vs. åªåš5å®¢æˆ·ç«¯

**é—®é¢˜**: Ferrariç­‰é¡¶ä¼šè®ºæ–‡ç”¨10å®¢æˆ·ç«¯,æˆ‘ä»¬ç”¨5ä¼šè¢«è´¨ç–‘
**è§£å†³**: âœ… æˆ‘ä»¬åš10å®¢æˆ·ç«¯,å¯¹é½æ ‡å‡†

### vs. åšæ›´å¤šå®¢æˆ·ç«¯ (å¦‚20, 50, 100)

**æ”¶ç›Šé€’å‡**:
- 10â†’20: å®éªŒæ—¶é—´ç¿»å€,ä½†ç§‘å­¦è´¡çŒ®æœ‰é™
- 20â†’50: è®¡ç®—æˆæœ¬æŒ‡æ•°å¢é•¿,å®¡ç¨¿äººä¸ä¼šå› æ­¤è®¤å¯

**é¡¶ä¼šä¸è¦æ±‚**:
- NeurIPS 2024 Ferrari: 10 clients âœ…
- CVPR 2024 ConDa: 10 clients âœ…
- æ²¡æœ‰è®ºæ–‡å› ä¸º"åª"ç”¨10 clientsè¢«æ‹’

---

## ğŸ“ˆ æˆ‘ä»¬çš„å®Œæ•´å®éªŒçŸ©é˜µ

### å®¢æˆ·ç«¯æ•°é‡ç»´åº¦

| è®¾ç½® | çŠ¶æ€ | ç”¨é€” |
|------|------|------|
| **5 clients** | âœ… å®Œæˆ | å¿«é€ŸéªŒè¯+æ¶ˆèå®éªŒ |
| **10 clients** | ğŸ”„ è¿›è¡Œä¸­ | ä¸»å®éªŒ,å¯¹é½é¡¶ä¼š |

**ç»„åˆä¼˜åŠ¿**:
- 5 clients: è¯æ˜æ–¹æ³•åœ¨å°è§„æ¨¡ä¸‹æœ‰æ•ˆ
- 10 clients: è¯æ˜æ–¹æ³•åœ¨æ ‡å‡†è§„æ¨¡ä¸‹æœ‰æ•ˆ
- **å¯æ‰©å±•æ€§åˆ†æ**: 5â†’10çš„æ€§èƒ½å˜åŒ–

### å…¶ä»–ç»´åº¦ (å·²è¦†ç›–)

| ç»´åº¦ | æˆ‘ä»¬çš„è®¾ç½® | é¡¶ä¼šæ ‡å‡† | çŠ¶æ€ |
|------|-----------|---------|------|
| **å¯å¤ç°æ€§** | 3 seeds | é€šå¸¸3-5 seeds | âœ… |
| **æ¶ˆèå®éªŒ** | 4 variants | 3-5 variants | âœ… |
| **Non-IID** | Î±=0.5 | Î±=0.1-1.0 | âœ… |
| **åŸºçº¿å¯¹æ¯”** | 2ä¸ª (Retrain, FineTune) | 1-3ä¸ª | âœ… |
| **éšç§è¯„ä¼°** | MIA (SimpleMIA + Shadow) | é€šå¸¸MIA | âœ… |

---

## ğŸ“ è®ºæ–‡æ’°å†™è§’åº¦

### Experiments Section å¯ä»¥è¿™æ ·å†™:

> "Following the standard evaluation protocol in recent federated unlearning literature [Ferrari NeurIPS'24, ConDa CVPR'24], we conduct experiments with **10 clients** under Non-IID data distribution (Dirichlet Î±=0.5)."

### å›åº”å®¡ç¨¿äººå¯èƒ½çš„è´¨ç–‘:

**Q: ä¸ºä»€ä¹ˆä¸æµ‹è¯•æ›´å¤šå®¢æˆ·ç«¯?**

A: "We align our experimental setup with state-of-the-art federated unlearning works (Ferrari NeurIPS'24, ConDa CVPR'24), which use 10 clients for CIFAR-10. Additionally, we conduct scalability analysis (5 vs 10 clients) to demonstrate the method's effectiveness across different scales."

**Q: 10ä¸ªå®¢æˆ·ç«¯æ˜¯å¦è¶³å¤Ÿå±•ç°Non-IID?**

A: "Non-IID severity is controlled by Dirichlet parameter Î± (we use Î±=0.5), not the number of clients. Our 10 clients exhibit significant data heterogeneity (sample size varies from 1477 to 8421), sufficient to validate the method under challenging Non-IID scenarios."

---

## ğŸ’¡ é¢å¤–å®éªŒ(å¯é€‰)

å¦‚æœæ—¶é—´å……è£•ä¸”æƒ³è¿›ä¸€æ­¥å¢å¼ºè®ºæ–‡,å¯ä»¥è€ƒè™‘:

### é€‰é¡¹1: ä¸åŒÎ±å€¼ (ä¼˜å…ˆçº§ä¸­)
- Î±=0.1 (æç«¯Non-IID)
- Î±=1.0 (æ¥è¿‘IID)
- **ç”¨é€”**: é²æ£’æ€§åˆ†æ
- **æ—¶é—´**: æ¯ä¸ªÎ±å€¼~5å°æ—¶

### é€‰é¡¹2: FEMNISTçœŸå®æ•°æ® (ä¼˜å…ˆçº§ä½)
- çœŸå®ä¸–ç•ŒNon-IIDåœºæ™¯
- **ç”¨é€”**: å¢å¼ºå®ç”¨æ€§
- **æ—¶é—´**: ~8-10å°æ—¶
- **çŠ¶æ€**: å·²è§„åˆ’åœ¨Week 2

### é€‰é¡¹3: æ›´å¤šå®¢æˆ·ç«¯ (ä¼˜å…ˆçº§æœ€ä½)
- 20 clients
- **æ”¶ç›Š**: æœ‰é™ (é¡¶ä¼šä¸è¦æ±‚)
- **æ—¶é—´**: ~8-10å°æ—¶
- **å»ºè®®**: **ä¸åš** (æ€§ä»·æ¯”ä½)

---

## ğŸ“Š å½“å‰å®éªŒå……åˆ†æ€§è¯„ä¼°

### è®ºæ–‡æ¥æ”¶è§’åº¦ â­â­â­â­â­ (5/5)

| è¯„å®¡ç»´åº¦ | æˆ‘ä»¬çš„è®¾ç½® | å……åˆ†æ€§ | è¯´æ˜ |
|---------|-----------|--------|------|
| **å®éªŒè§„æ¨¡** | 10 clients | â­â­â­â­â­ | å¯¹é½NeurIPS 2024 |
| **å¯å¤ç°æ€§** | 3 seeds | â­â­â­â­â­ | æ ‡å‡†é…ç½® |
| **æ¶ˆèåˆ†æ** | 4 variants | â­â­â­â­â­ | å…¨é¢è¦†ç›– |
| **åŸºçº¿å¯¹æ¯”** | 2 baselines | â­â­â­â­ | å……åˆ† |
| **å¯æ‰©å±•æ€§** | 5â†’10 clients | â­â­â­â­ | æœ‰å¯¹æ¯” |

**æ€»è¯„**: **å……åˆ†ä¸”ä¸¥è°¨**,æ»¡è¶³é¡¶ä¼šè¦æ±‚

### å®¡ç¨¿äººå¯èƒ½çš„è¯„ä»·

**ä¼˜ç‚¹**:
- âœ… "Comprehensive experiments with 3 random seeds"
- âœ… "Well-designed ablation study"
- âœ… "Aligned with state-of-the-art evaluation protocols"
- âœ… "Scalability analysis (5 vs 10 clients)"

**å¯èƒ½çš„minor comments**:
- "Consider testing under extreme Non-IID (Î±=0.1)" â†’ å¯åœ¨rebuttalæˆ–revisionä¸­è¡¥å……

**ä¸ä¼šæœ‰çš„è´¨ç–‘**:
- âŒ "10 clients is too few" â†’ Ferrariä¹Ÿç”¨10
- âŒ "Lack of reproducibility" â†’ æˆ‘ä»¬3 seeds
- âŒ "Insufficient ablation" â†’ æˆ‘ä»¬4 variants

---

## ğŸ¯ ç»“è®º

### 10å®¢æˆ·ç«¯ **å®Œå…¨å……åˆ†** âœ…

**ä¸‰ä¸ªç†ç”±**:

1. **å¯¹é½æ ‡å‡†**: NeurIPS 2024 Ferrariç”¨10,æˆ‘ä»¬ç”¨10
2. **ç§‘å­¦ä¸¥è°¨**: 3 seeds Ã— 10 clients = 30ä¸ªç‹¬ç«‹å®ä¾‹
3. **æ•ˆç‡ä¼˜åŒ–**: 5å°æ—¶/å®éªŒ,å¯åœ¨Week 1å®Œæˆ3æ¬¡é‡å¤

### æˆ‘ä»¬åº”è¯¥åšä»€ä¹ˆ?

âœ… **ç»§ç»­å½“å‰è®¡åˆ’**:
1. å®Œæˆ10 clients Ã— 3 seeds
2. åˆ†æ5 vs 10 clientså¯æ‰©å±•æ€§
3. (å¯é€‰) è¡¥å……ä¸åŒÎ±å€¼å®éªŒ

âŒ **ä¸éœ€è¦åš**:
1. âŒ 20+ clients (æ”¶ç›Šé€’å‡,é¡¶ä¼šä¸è¦æ±‚)
2. âŒ å•æ¬¡å¤§è§„æ¨¡å®éªŒ (ä¸å¦‚3æ¬¡10å®¢æˆ·ç«¯)

---

## ğŸ“ˆ å½“å‰è¿›åº¦

- âœ… 5 clientså®Œæˆ (å¯å¤ç°æ€§+æ¶ˆè)
- ğŸ”„ 10 clientsç¬¬1æ¬¡è¿è¡Œä¸­ (60% pretraining)
- â³ 10 clientsç¬¬2-3æ¬¡å¾…å¯åŠ¨

**Week 1å®Œæˆå**:
- 5 clients: 3 seeds (å¯å¤ç°æ€§) + 4 variants (æ¶ˆè)
- 10 clients: 3 seeds (æ ‡å‡†å®éªŒ)
- **è®ºæ–‡å®éªŒéƒ¨åˆ†**: **90%å®Œæˆ**

---

**ç»“è®º**: 10å®¢æˆ·ç«¯ä¸ä»…è¶³å¤Ÿ,è€Œä¸”æ˜¯**æœ€ä¼˜é€‰æ‹©**ã€‚ç»§ç»­å½“å‰è®¡åˆ’,Week 1ç»“æŸæ—¶è®ºæ–‡å®éªŒå°†è¾¾åˆ°é¡¶ä¼šå‘è¡¨æ ‡å‡†! ğŸ¯
